Table 1. Biodistribution of radioactivity in NMRI mice after ip injections of 111In-DOTA-3A3 (40 μg and 160 μg – single injection, 40 μg repeated – 40 μg of non-labelled 3A3 were injected ip 24 h before 111In-DOTA-3A3).
6 h* | 24 h* | 48 h* | 72 h* | 168 h* | 24 h** | ||
---|---|---|---|---|---|---|---|
40 μg | 40 μg repeated | 160 μg | |||||
Blood | 7.9 ± 0.7 | 1.64 ± 0.02a | 0.32 ± 0.04a | 0.11 ± 0.01a | 0.022 ± 0.010a | 1.4 ± 0.2 | 1.8 ± 0.3 |
Lung | 4.3 ± 0.6 | 3.7 ± 0.4 | 1.9 ± 0.2a | 1.2 ± 0.1a | 0.27 ± 0.04a | 1.4 ± 0.3c | 1.6 ± 0.2c |
Liver | 6.2 ± 0.9 | 6 ± 1 | 5.37 ± 0.09 | 4.58 ± 0.08a | 1.07 ± 0.05a | 2.7 ± 0.5c | 3.1 ± 0.6c |
Spleen | 4.6 ± 0.7 | 7 ± 2 | 7.0 ± 0.6a | 6 ± 2a | 4 ± 1a | 1.63 ± 0.03c | 1.7 ± 0.4c |
Kidneys | 24 ± 3 | 17.1 ± 0.9 | 13.4 ± 0.5a | 10 ± 1a | 2.5 ± 0.2a | 38 ± 5d | 42 ± 5d |
Muscle | 0.9 ± 0.2 | 0.68 ± 0.03a | 0.42 ± 0.03a | 0.31 ± 0.03a | 0.10 ± 0.02a | 0.40 ± 0.04c,e | 0.49 ± 0.03c |
Bone | 1.7 ± 0.1 | 2.2 ± 0.2b | 1.58 ± 0.06 | 1.1 ± 0.3 | 0.49 ± 0.05 | 0.8 ± 0.1c | 1.0 ± 0.2c |
GI tract*** | 14 ± 2 | 10 ± 2a | 6.8 ± 0.6a | 4.8 ± 0.4a | 1.46 ± 0.09a | 3.9 ± 0.4c | 2.0 ± 0.1c |
Carcass*** | 30.5 ± 0.8 | 25.4 ± 0.9a | 18 ± 1a | 12.4 ± 0.5a | 4.0 ± 0.2a | 35 ± 3d | 34.8 ± 1.0d |
Results are presented as average of percent injected dose per gram tissue (%ID/g) for 4 animals ± SD. *Data were assessed by an unpaired, two-tailed t-test in order to determine significant differences (p < 0.05). **Data were analysed together with data for 24 h using one-way ANOVA with Bonferroni correction for multiple comparisons (family-wise significance 0.05). ***Values for GI (gastrointestinal) tract and carcass are given as %ID per whole sample. aValue is significantly lower than for the previous time point. bValue is significantly higher than for the previous time point. cValue is significantly lower than for 24 h pi of single dose of 40 μg (at least **P ≤ 0.01). dValue is significantly higher than for 24 h pi of single dose of 40 μg (at least **P ≤ 0.01) e - value is significantly lower than for 24 h pi of single dose of 160 μg (*P ≤ 0.01).